Clinical Trials Directory

Trials / Conditions / Cadonilimab

Cadonilimab

6 registered clinical trials studyying Cadonilimab — 5 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationEvaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendoc
NCT06810895
Ding Ma—
RecruitingCadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Neg
NCT06367088
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2
RecruitingNALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
NCT06405490
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
RecruitingCryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastase
NCT06265350
Sun Yat-sen UniversityN/A
RecruitingCadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unrese
NCT06218810
Fudan UniversityPhase 2
CompletedCadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
NCT06138496
Sun Yat-sen UniversityPhase 2